PYK2 promotes HER2-positive breast cancer invasion

BACKGROUND: Metformin, a biguanide, is one of the most commonly prescribed treatments for type 2 diabetes and has recently been recommended as a potential drug candidate for advanced cancer therapy. Although Metformin has antiproliferative and proapoptotic effects on breast cancer, the heterogenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Juboori, Shaymaa IK., Vadakekolathu, Jayakumar, Idri, Sarra, Wagner, Sarah, Zafeiris, Dimitrios, Pearson, Joshua RD., Almshayakhchi, Rukaia, Caraglia, Michele, Desiderio, Vincenzo, Miles, Amanda K., Boocock, David J., Ball, Graham R., Regad, Tarik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532260/
https://www.ncbi.nlm.nih.gov/pubmed/31118051
http://dx.doi.org/10.1186/s13046-019-1221-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532260/
https://www.ncbi.nlm.nih.gov/pubmed/31118051
http://dx.doi.org/10.1186/s13046-019-1221-0

Ejemplares similares